Filters
Hikma completes its FDA response for generic Advair®
Press Release, Corporate
Hikma Ventures leads Series A financing for development of Winterlight Labs’ AI vocal technology to detect central nervo...
Press Release, Corporate
Hikma continues strong 2019 performance and reiterates full year guidance
Press Release, Corporate
Hikma launches prefilled syringes in the US
Press Release, Product
Hikma launches Phenylephrine Hydrochloride Injection, USP
Press Release, Product
Hikma acquisition expands nasal spray capabilities and pipeline
Press Release, Corporate
Hikma delivers strong first half results and raises full year guidance
Press Release, Corporate
Hikma appoints Dr Shahin Fesharaki as Chief Scientific Officer and Global Head of R&D
Press Release, Corporate
Hikma remains constituent of the FTSE4Good Index Series for 5th consecutive year
Press Release, Corporate
Hikma and Richter sign a license and supply agreement for cariprazine in MENA
Press Release, Corporate
Hikma and Civica Rx sign long-term agreement to reduce generic drug shortages in the US
Press Release, Corporate